In addition, electrokinetic therapy using nanotechnology in combination with electronic currents can also be used with the glutamine antagonist 6-diazo-5-oxo-1-leucine (DON) (glutamine mimetics) to promote CD8+ T cell infiltration and inhibit primary or metastatic tumours [123]. Here, CD8A is linked to neoplasm.